Taflan Salepçi

1.2k total citations
40 papers, 803 citations indexed

About

Taflan Salepçi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Taflan Salepçi has authored 40 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Taflan Salepçi's work include Gastric Cancer Management and Outcomes (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal and Anal Carcinomas (5 papers). Taflan Salepçi is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal and Anal Carcinomas (5 papers). Taflan Salepçi collaborates with scholars based in Türkiye, United Kingdom and Serbia. Taflan Salepçi's co-authors include Ahmet Bılıcı, Mesut Şeker, Bala Başak Öven Ustaalıoğlu, Mahmut Gümüş, Umut Kefeli, Emre Yıldırım, Dilek Yavuzer, Perran Fulden Yumuk, Berkant Sönmez and Faysal Dane and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Surgical Oncology.

In The Last Decade

Taflan Salepçi

40 papers receiving 790 citations

Peers

Taflan Salepçi

ONCOL

EPIDE

SURGE

PRM

PFM

Kazım Uygun Türkiye

Kazuhisa Yabushita Japan

Jong Lyul Lee South Korea

M Latteri Italy

Francesca Erroi Italy

Gabriel Zozaya Spain

Ayman H. Gaballah United States

Won Young Park South Korea

Semen Önder Türkiye

Francesco Stipa Italy

Kazım Uygun Türkiye

Taflan Salepçi

312 ×0.8

ONCOL

187 ×0.7

EPIDE

155 ×0.6

SURGE

215 ×1.0

PRM

98 ×0.9

PFM

Citations per year, relative to Taflan Salepçi Taflan Salepçi (= 1×) peers Kazım Uygun

Countries citing papers authored by Taflan Salepçi

Since Specialization

Citations

This map shows the geographic impact of Taflan Salepçi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taflan Salepçi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taflan Salepçi more than expected).

Fields of papers citing papers by Taflan Salepçi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taflan Salepçi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taflan Salepçi. The network helps show where Taflan Salepçi may publish in the future.

Co-authorship network of co-authors of Taflan Salepçi

This figure shows the co-authorship network connecting the top 25 collaborators of Taflan Salepçi. A scholar is included among the top collaborators of Taflan Salepçi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taflan Salepçi. Taflan Salepçi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saip, Pınar, Serkan Keskın, Güzin Demirağ, et al.. (2011). TÜRKİYE’xxDE MEME KANSERLİ HASTALARIN TANI VE TEDAVİ YÖNTEMLERİNE ULAŞIM HIZI ÇOK MERKEZLİ GÖZLEMSEL ÇALIŞMA.. 7(2). 109–117. 2 indexed citations

Ustaalıoğlu, Bala Başak Öven, Ahmet Bılıcı, Umut Kefeli, et al.. (2010). Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences. Oncology. 79(1-2). 105–111. 8 indexed citations

Kefeli, Umut, Serap Kaya, Bala Başak Öven Ustaalıoğlu, et al.. (2010). Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience. Medical Oncology. 28(3). 661–666. 11 indexed citations

Bılıcı, Ahmet, Bala Başak Öven Ustaalıoğlu, Mahmut Gümüş, et al.. (2010). Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?. Oncology Research and Treatment. 33(3). 101–105. 15 indexed citations

Gümüş, Mahmut, Bala Başak Öven Ustaalıoğlu, Emre Kiziltan, et al.. (2010). Factors that Affect Patients’ Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients. Breast Care. 5(3). 164–168. 34 indexed citations

Bılıcı, Ahmet, Bala Başak Öven Ustaalıoğlu, Mesut Şeker, et al.. (2010). Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?. European Journal of Nuclear Medicine and Molecular Imaging. 37(7). 1259–1269. 28 indexed citations

Bılıcı, Ahmet, Bala Başak Öven Ustaalıoğlu, Asuman Orçun, et al.. (2010). Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?. Cancer Chemotherapy and Pharmacology. 68(2). 309–316. 15 indexed citations

Yavuzer, Dilek, et al.. (2010). Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas. Medical Oncology. 28(1). 127–132. 38 indexed citations

Bılıcı, Ahmet, Kazım Uygun, Mesut Şeker, et al.. (2010). The Effect of Tumor Size on Overall Survival in Patients with pT3 Gastric Cancer: Experiences from 3 Centers. Onkologie. 33(12). 676–682. 14 indexed citations

10.

Yavuzer, Dilek, et al.. (2010). Role of human papillomavirus in the development of urothelial carcinoma. Medical Oncology. 28(3). 919–923. 28 indexed citations

11.

Ustaalıoğlu, Bala Başak Öven, Mesut Şeker, Ahmet Bılıcı, et al.. (2010). The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Medical Oncology. 28(1). 258–264. 7 indexed citations

12.

Bılıcı, Ahmet, Taflan Salepçi, Faysal Dane, et al.. (2009). Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience. Archives of Gynecology and Obstetrics. 282(4). 417–425. 15 indexed citations

13.

Salepçi, Taflan, Mesut Şeker, Hüseyin Uyarel, et al.. (2009). 5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels. Medical Oncology. 27(2). 416–420. 29 indexed citations

14.

Şeker, Mesut, Ahmet Bılıcı, Berkant Sönmez, et al.. (2009). The association of serum adiponectin levels with histopathological variables in gastric cancer patients. Medical Oncology. 27(4). 1319–1323. 21 indexed citations

15.

Ustaalıoğlu, Bala Başak Öven, Ahmet Bılıcı, Mesut Şeker, et al.. (2009). Metastasis of Lobular Breast Carcinoma to the Uterus in a Patient under Anastrozole Therapy. Onkologie. 32(7). 10–10. 16 indexed citations

16.

Bılıcı, Ahmet, Mesut Şeker, Bala Başak Öven Ustaalıoğlu, et al.. (2009). Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer. Medical Oncology. 27(3). 975–984. 14 indexed citations

17.

Bılıcı, Ahmet, Mesut Şeker, Tarık Salman, et al.. (2009). Metastatic renal hemangiopericytoma: A rare case report. Archive of oncology. 17(1-2). 32–35. 1 indexed citations

18.

Koldaş, Macit, et al.. (2008). Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 9(2). 112–115. 13 indexed citations

19.

Gemici, Cengiz, et al.. (2006). Preoperative radiation in combination with uracil/tegafur (UFT) and mitomycin C (MMC) in locally advanced rectal adenocarinoma. Journal of Clinical Oncology. 24(18_suppl). 13512–13512. 1 indexed citations

20.

Yumuk, Perran Fulden, Nazım Serdar Turhal, Mahmut Gümüş, et al.. (2005). Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer. BMC Cancer. 5(1). 10–10. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact